Johnson & Johnson Innovative Medicine company-sponsored congress materials which have been accepted for congress presentation at European Association of Urology

Longitudinal Assessment of Urine Tumor DNA in High‑Risk Non‑Muscle Invasive Bladder Cancer Patients

CARVYKTI_US-SR-10459

rybrevant dossier update - bottom

Lazcluze Dossier Update - bottom

Talvey Digital Dossier banner

CARVYKTI_US-SR-10545

Imaavy Dossier banner

Test-EL

Externally Sponsored Scientific Research

Submit your medical inquiry

Contact J&J Medical Connect for your medical inquiries


This page was last modified on

Additional contact #{index}

janssenscience

Congress Materials

Payer

Dark Blue

oncology

longitudinal-assessment-of-urine-tumor-dna-video

Whitelist Modal

Longitudinal Assessment of Urine Tumor DNA in High‑Risk Non‑Muscle Invasive Bladder Cancer Patients

Connect with us

Connect with us

Live video

Waiting for agent...

Ready to join